Six Area, Six Sign Atopic Dermatitis (SASSAD) seventy score: A simple system for monitoring disease activity in atopic dermatitis

British Journal of Dermatology, Supplement

Volumn 135, Issue 48, 1996, Pages 25-30

  Berth Jones, J ^a  

^a WALSGRAVE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ATOPIC DERMATITIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

DERMATITIS, ATOPIC; ERYTHEMA; EXUDATES AND TRANSUDATES; HUMANS; LICHENOID ERUPTIONS; MEDICAL RECORDS; SEVERITY OF ILLNESS INDEX;

EID: 0029816049     PISSN: 0366077X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Lever R, Hadley K, Downey I), MacKie R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 1988: 119: 189-98.
2. Berth-Jones J. Graham-Brown RAC. Failure of papaverine to reduce pruritus in atopic dermatitis. Br J Dermatol 1990; 122: 553-7.
3. Berth-Jones J. Graham-Brown RAC. Essential fatty acid supplementation in atopic dermatitis: a placebo-controlled trial. Lancet 1993: 341: 1557-60.
4. Costa C, Rilliet A. Nicolet M, Saurat J-H. Scoring atopic dermatitis: The simpler the better? Acta Derm Venereal (Stockli) 1989:69:41-5.
5. Shechcn MP, Atherton DJ. A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema. Br J Dermatol 1992; 126: 179-84.
6. Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186: 23-31.
7. Salek MS, Finlay AY, Luscombe DK et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. Br J Dermatol 1993: 129: 422-30.
8. Finlay AY, Khan GK. Dermatology life quality index (DLQI) -a simple practical measure for routine clinical use. Clin Exp Dermatol 1994: 19:210-6.
9. Lewis-Jones MS. Finlay AY. The children's dermatology lire quality index (CPI.QI): initial validation and practical use. Br J Dermatol 1995: 132:942-9.
10. Chren MM, Lasek RJ, Quinn LM, Zyzanski SJ. A measure of the effect of skin disease on quality of life: conceptual framework and initial tests. J Invest Med 1995: 43: 348A.
11. Tan B. Weald D. Strickland I, Fricdmann PS. Double-blind controlled trial of effect of house dust-mite allergen avoidance on atopic dermatitis. Lancet 1996: 347: 15-8.
12. Berth-Jones J, Finlay AY, Zaki I et al, Cyclosporin in severe childhood atopic dermatitis: a multicentre study. J Am Acad Derinatol 1996: 34: 1016-21.
13. Sowden JM, lierth-Joncs J, Ross J et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 1991; 338: 137-40.
14. Berth-Jones J. Graham-Brown RAC. Marks R et al. Long-term . efficacy and safety of cyclosporin in severe adult atopic dermatitis. Er J Dcrmatol 1996; in press.
15. Granlund H. Erkko P, Sinisalo M, Reitamo S. Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy. Br J Dermatol 1995; 132: 106-12.